[Pharmacological correction of disorders of the prostacyclin- thromboxane balance in ischemic heart disease: problems and prospects].
Markov
Kh M
KhM
D001241:Aspirin / Q000008:administration & dosage* / Q000494:pharmacology; D003327:Coronary Disease / Q000097:blood* / Q000150:complications; D011464:Epoprostenol / Q000096:biosynthesis / Q000097:blood*; D006801:Humans; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000097:blood*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors / Q000097:blood
D013928:Thromboxane A2; D011464:Epoprostenol; D013930:Thromboxane-A Synthase; D001241:Aspirin
Farmakologicheskaia korrektsiia narusheniĭ prostatsiklin- tromboksanovogo balansa pri ishemicheskoĭ bolezni serdtsa: problemy i perspektivy.